|Bid||0.00 x 1000|
|Ask||0.00 x 800|
|Day's range||253.85 - 263.00|
|52-week range||124.53 - 312.12|
|Beta (5Y monthly)||0.99|
|PE ratio (TTM)||57.42|
|Earnings date||21 Apr 2021 - 26 Apr 2021|
|Forward dividend & yield||0.68 (0.26%)|
|Ex-dividend date||20 Apr 2021|
|1y target est||328.00|
ESG investing will continue its northward momentum and this calls for investing in NVIDIA (NVDA), Microsoft (MSFT), EMCOR (EME), West Pharma (WST) and Texas Instruments (TXN)
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a second-quarter 2021 dividend of $0.17 per share. The dividend will be paid on May 5, 2021, to shareholders of record as of April 21, 2021.
Ladies and gentlemen, thank you for standing by and welcome to the fourth-quarter 2020 West Pharmaceutical Services earnings conference call. This morning, CEO Eric Green and CFO Bernard Birkett will review our financial results, provide an update on our business and present our financial outlook for the full year of 2021.